Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Previous close
$339.09
−$2.16 · -0.63%
Regular session · ET · Market data may be delayed.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Day range
Current $339.09
52-week range
Current $339.09
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
91
Deep Value
Sentiment
60
Mixed
Risk
23
Moderate Risk
Momentum
43
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Day range
Current $339.09
52-week range
Current $339.09
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 337.4B USD | 321.33B USD | 293.96B USD | 262.17B USD | 238.59B USD |
| Cost of goods sold | 323.53B USD | 311.19B USD | 285.26B USD | 254.42B USD | 230.99B USD |
| Gross profit | 13.87B USD | 10.14B USD | 8.7B USD | 7.76B USD | 7.6B USD |
| Selling, general, and administrative | 8.08B USD | 6.49B USD | 5.66B USD | 5.31B USD | 4.85B USD |
| Operating expenses | 9.94B USD | 6.49B USD | 5.66B USD | 5.31B USD | 4.85B USD |
| Interest income | — | 128.21M USD | 91.69M USD | 46.72M USD | 21.31M USD |
| Interest expense | 489.86M USD | 419.75M USD | 248.68M USD | 275.65M USD | 231.98M USD |
| Depreciation and amortization | 1.05B USD | 1.07B USD | 1.12B USD | 980.85M USD | 709.84M USD |
| Operating income | 3.93B USD | 3.65B USD | 3.04B USD | 2.45B USD | 2.75B USD |
| Net income | 3.48B USD | 1.55B USD | 1.51B USD | 1.75B USD | 1.7B USD |
Company facts updated Nov 22, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Third-party consensus; not a GoAI recommendation.
Average target
$364
7.35% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 16, 2009 | 2:1 | — | — |
Stock split | Dec 29, 2005 | 2:1 | — | — |
Stock split | Mar 25, 1999 | 2:1 | — | — |
Effective Jun 16, 2009
2:1
Effective Dec 29, 2005
2:1
Effective Mar 25, 1999
2:1
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T125.81B0.11%119.91T JPY0.09%¥113,700-3.19%
Vanguard S&P 500 ETFVOO1.68B0.10%1T USD0.03%$635.54-3.41%
Vanguard Morningstar Total Stock Market ETFVTI1.5B0.08%689.3B USD0.03%$340.02-3.52%
Vanguard Morningstar Mid-Cap ETFVO1.28B0.57%107.4B USD0.03%$76.25-2.22%
iShares Core S&P 500 ETFIVV877.32M0.11%803.41B USD0.03%$693.71-3.52%
State Street SPDR S&P 500 ETFSPY793.56M0.11%756.38B USD0.09%$689.81-3.64%
Vanguard Morningstar Value ETFVTV576.53M0.22%195.9B USD0.03%$214.22-1.62%
State Street Health Care Select Sector SPDR ETFXLV474.97M1.01%46.92B USD0.08%$177.24-0.12%
State Street SPDR S&P 500 ETF1557.T
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLVAI-generated and delayed market data for informational and educational purposes only. Not investment advice.